ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

133 hedge funds and large institutions have $815M invested in Aclaris Therapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 19 closing their positions.

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
2.05%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
28
Increased
49
Reduced
37
Closed
19
Calls
$2.15M
Puts
$31K
Net Calls
+$2.12M
Net Calls Change
+$595K

Top Buyers

1
LCM
1
Laurion Capital Management
New York
$16.2M
2
CC
2
Commodore Capital
New York
$38.9M
3
O
3
OrbiMed
New York
$14.3M
4
BI
4
BVF Inc
California
$24.7M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$6.78M

Top Sellers

1
FCMI
1
Foresite Capital Management III
California
$0
2
WP
2
Woodline Partners
California
$0
3
CAM
3
Cormorant Asset Management
Massachusetts
$13.1M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$0
5
Invesco
5
Invesco
Georgia
$354K
Name Holding Trade Value Shares
Change 		Shares
Change %
OSAM
151
O'Shaughnessy Asset Management
Connecticut
– -$5K -288 Closed
RE
152
RBC Europe
United Kingdom
– -$3.51K -195 Closed
3 4 5 6
7